Intas Pharmaceuticals Ltd - Company Profile

All the sales intelligence you need on Intas Pharmaceuticals Ltd in one solution.

Save hours of research time with a comprehensive
Sales Intelligence Solution.
Understand how Intas Pharmaceuticals Ltd fits into your total
addressable market and Ideal Customer Profile.
Gain competitive edge with triggers that tell you
when and how to engage with Intas Pharmaceuticals Ltd.

Intas Pharmaceuticals Ltd: Premium Databases

Contact the team or request a demo to find out how our data can drive your business forward

Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.

Headline	Published	Journalists
Showing 3 of 8 results.
Deserunt mollit sunt Lorem laborum do id aliqua dolore	26 Jan 2017	Lorem
Adare welcomes CRO pitches for 1H17 contracts for Phase I muscle and Phase II sleep disorders trials – CEO	12 Oct 2016	Fiona Barry
Intas Pharma eyes 40-50 generic out-licensing deals by YE15 - executive	06 May 2015	Jennifer C. Smith-Parker
UK MHRA inspections: 4Q13 major GMP deficiencies uncovered at CDMOs, CROs and other service providers - special report	26 Feb 2014	Natalie Morrison

Delivers exclusive investigative journalist content including breaking news and analysis ahead of market-moving events.

Drug Insights:

Forward-looking, nuanced, qualitative asset analysis on development, approval & market/reimbursement potential
Material intelligence on competitors, including breaking news
Insight on companies’ business development needs and strategies

Outsourcing Insights:

Insight on companies’ CRO and business development needs, strategies and relationships

Remove risk and uncertainty

Gain a competitive edge

Secure actionable leads

Gain a 360-degree view of Intas Pharmaceuticals Ltd and make more informed decisions for your business

Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer